Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants

Fig. 1

Characterization of hybrid NVRBD-MLipo. The size, zeta potential (A) and TEM images (B) of NVRBD, MLipo and NVRBD-MLipo (n = 3). (C) Alternation of particle size of NVRBD, MLipo, NVRBD-MLipo in serum (n = 3). (D) CLSM images of physical mixture (NVRBD and MLipo) and NVRBD-MLipo. (red, Rhodamine B-labelled MLipo; green, FITC-labelled NVRBD). (E) FCM analysis of membrane fusion in NVRBD-MLipo. (F) Western blot analysis of RBD protein expression in NVRBD, MLipo and NVRBD-MLipo

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us